S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RIGL Rigel Pharmaceuticals Inc

16.44

-0.71 (-4.14%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals (NASDAQ:RIGL)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Rigel Pharmaceuticals Charts.

Rigel Pharmaceuticals Inc News

Form 8-K - Current report
Monday 9 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition
Monday 9 December 2024 (2 weeks ago) • PR Newswire (US)

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Monday 2 December 2024 (3 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Rigel to Present at the Jefferies London Healthcare Conference
Tuesday 12 November 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
Thursday 7 November 2024 (2 months ago) • PR Newswire (US)

More Rigel Pharmaceuticals Inc News Articles

Digital Brand Media and ... (PK)

Anavex Life Sciences

Intergrated Cannabis Sol... (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Code Green Apparel (PK)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions